Seyitler Kimya Sanayi A.S.

IBSE:SEYKM Stock Report

Market Cap: ₺658.0m

Seyitler Kimya Sanayi Past Earnings Performance

Past criteria checks 0/6

Seyitler Kimya Sanayi's earnings have been declining at an average annual rate of -41%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been growing at an average rate of 38.2% per year.

Key information

-41.0%

Earnings growth rate

-38.3%

EPS growth rate

Medical Equipment Industry Growth12.3%
Revenue growth rate38.2%
Return on equity-4.0%
Net Margin-9.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Seyitler Kimya Sanayi makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

IBSE:SEYKM Revenue, expenses and earnings (TRY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24160-16450
30 Jun 24153-48520
31 Mar 24141-67470
31 Dec 23196-70520
30 Sep 23335-75750
30 Jun 23297-16600
31 Mar 232884550
31 Dec 2221351390
30 Sep 2210168180
30 Jun 228943150
31 Mar 227632140
31 Dec 216024130
30 Sep 215523120
30 Jun 215424100
31 Mar 215124100
31 Dec 20532080
30 Sep 20491170
30 Jun 2040960
31 Mar 2039850
31 Dec 1933550
30 Sep 1928340
30 Jun 1929340
31 Mar 1926240
31 Dec 1824330
30 Sep 1821230
30 Jun 1818230
31 Mar 1818230
31 Dec 1717230
30 Sep 1717330
30 Jun 1717320
31 Mar 1716320
31 Dec 1614320
30 Sep 1613220
30 Jun 1612220
31 Mar 1613220
31 Dec 1513220
30 Sep 1514220
30 Jun 1514320
31 Mar 1514320
31 Dec 1413220

Quality Earnings: SEYKM is currently unprofitable.

Growing Profit Margin: SEYKM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SEYKM is unprofitable, and losses have increased over the past 5 years at a rate of 41% per year.

Accelerating Growth: Unable to compare SEYKM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SEYKM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-2.8%).


Return on Equity

High ROE: SEYKM has a negative Return on Equity (-3.98%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 00:52
End of Day Share Price 2025/01/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Seyitler Kimya Sanayi A.S. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution